Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

March 8, 2024

https://www.globenewswire.com/news-release/2024/03/07/2842715/0/en/Adagene-Appoints-Heinz-Josef-Lenz-M-D-FACP-to-Scientific-and-Strategic-Advisory-Board.html

– Global oncology expert brings deep insight in colorectal cancer and role of CTLA-4 therapy as a cornerstone for combination immunotherapy –

SAN DIEGO and SUZHOU, China, March 07, 2024 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq:ADAG), a company transforming the discovery and development of antibody-based therapies, today announced the appointment of Heinz-Josef Lenz, M.D., FACP, to its Scientific and Strategic Advisory Board (the “SAB”).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.